Cannell & Spears’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$226K Buy
+2,926
New +$213K ﹤0.01% 411
2026
Q1
Sell
-2,914
Closed -$231K 446
2025
Q4
$231K Buy
+2,914
New +$223K ﹤0.01% 383
2025
Q3
Sell
-2,898
Closed -$220K 423
2025
Q2
$220K Sell
2,898
-7
-0.2% -$496 ﹤0.01% 358
2025
Q1
$221K Sell
2,905
-922
-24% -$68.7K ﹤0.01% 354
2024
Q4
$253K Sell
3,827
-221
-5% -$15.5K 0.01% 353
2024
Q3
$282K Buy
+4,048
New +$243K 0.01% 346

Other funds holding SOLV

Cannell & Spears's SOLV Position: Q2 2026 in Review

Cannell & Spears opened a new position in Solventum (SOLV) in Q2 2026: 2,926 shares worth $226K. The stake represents ﹤0.01% of the portfolio and ranks #411 among its holdings. This is a return to the name: Cannell & Spears previously reported a position in SOLV as recently as Q4 2025.

Cannell & Spears first reported a position in SOLV in Q3 2024 and has held it in 6 quarters since. The position peaked at $282K in Q3 2024. 875 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Cannell & Spears held 2,926 shares of Solventum worth $226K as of Q2 2026.
  • Solventum was a new Cannell & Spears position in Q2 2026.
  • Solventum made up ﹤0.01% of Cannell & Spears's portfolio in Q2 2026, its #411 holding.
  • Cannell & Spears first reported a position in Solventum in Q3 2024 and has held it in 6 quarters since.
  • Cannell & Spears's Solventum position peaked at $282K in Q3 2024.
  • 875 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Cannell & Spears's 13F filing for Q2 2026, filed 11 Aug 2026.